Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion™ Exceed LB CT system, giving clinicians the opportunity to see more during radiation therapy planning for accuracy, precision and speed. As cancer cases continue to increase in the U.S., providing clinicians with the latest technology for accurate simulation across treatment plans remains critical.
The Aquilion Exceed LB supports fast and efficient radiation oncology workflows without compromising on patient position, image quality, or reproducibility. Features include:
“The Aquilion Exceed LB was designed to push the boundaries of traditional simulation,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”Back To Top
FDA Clears Canon's AI-Powered Large-Bore Aquilion Exceed LB CT. Appl Rad Oncol.